Pathological features of response to neoadjuvant chemotherapy in malignant pleural mesothelioma

被引:0
|
作者
Sharkey, A. [1 ]
Le Quesne, J. [1 ]
Fennell, D. [1 ]
Nakas, A. [1 ]
Richards, C. [1 ]
Waller, D. [1 ]
Muller, S. [1 ]
机构
[1] Glenfield Hosp, Dept Thorac Surg, Leicester, Leics, England
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
PS-25-054
引用
收藏
页码:S373 / S373
页数:1
相关论文
共 50 条
  • [41] Current concepts in chemotherapy for malignant pleural mesothelioma
    Sorensen, Jens Benn
    CLINICAL RESPIRATORY JOURNAL, 2008, 2 (02): : 74 - 79
  • [42] Malignant pleural mesothelioma: maintenance chemotherapy with pemetrexed
    Nacci, A.
    Rizzo, P.
    Sponziello, F.
    Mazzoni, E.
    Fedele, P.
    Orlando, L.
    Schiavone, P.
    Calvani, N.
    Marino, A.
    Cinieri, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S833 - S833
  • [43] Current chemotherapy strategies in malignant pleural mesothelioma
    de Gooijer, Cornedine Jannette
    Baas, Paul
    Burgers, Jacobus Adrianus
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (05) : 574 - 583
  • [44] Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma
    Carey, George B.
    Kazantsev, Stephanie
    Surati, Mosmi
    Rolle, Cleo E.
    Kanteti, Archana
    Sadiq, Ahad
    Bahroos, Neil
    Raumann, Brigitte
    Madduri, Ravi
    Dave, Paul
    Starkey, Adam
    Hensing, Thomas
    Husain, Aliya N.
    Vokes, Everett E.
    Vigneswaran, Wickii
    Armato, Samuel G., III
    Kindler, Hedy L.
    Salgia, Ravi
    BMJ OPEN, 2012, 2 (05):
  • [45] Pleural mesothelioma: neoadjuvant chemotherapy plus pleurectomy/decortication
    Lorenz, Judith
    ZENTRALBLATT FUR CHIRURGIE, 2022, 147 : S4 - S4
  • [46] Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma
    Opitz, I
    Kestenhoz, P
    Lardinois, D
    Müller, M
    Rousson, V
    Schneiter, D
    Stahel, R
    Weder, W
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2006, 29 (04) : 579 - 584
  • [47] Clinical and pathological predictors of outcome for malignant pleural mesothelioma
    Fiordoliva, I.
    Berardi, R.
    Ballatore, Z.
    De Lisa, M. G.
    Caramanti, M.
    Morgese, F.
    Savini, A.
    Rinaldi, S.
    Torniai, M.
    Tiberi, M.
    Ferrini, C.
    Onofri, A.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2015, 26 : 88 - 88
  • [48] The Role of Neoadjuvant Chemotherapy in Patients With Resectable Malignant Pleural Mesothelioma-An Institutional and National Analysis
    Voigt, Soraya L.
    Raman, Vignesh
    Jawitz, Oliver K.
    Bishawi, Muath
    Yang, Chi-Fu Jeffrey
    Tong, Betty C.
    D'Amico, Thomas A.
    Harpole, David H.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (11): : 1118 - 1126
  • [49] A Model for Approaching Pathologic Assessment of Treatment Response to Neoadjuvant Chemotherapy in Resected Pleural Mesothelioma
    Aly, Rania G.
    Offin, Michael
    Tan, Kay See
    Bodd, Francis
    Adusumilli, Prasad
    Travis, William
    Zauderer, Marjorie
    Sauter, Jennifer
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1895 - S1895
  • [50] Multicenter Study of Histological Types Incidence and Pathological Features of Malignant Pleural Mesothelioma (MPM) in AR
    Poleri, C.
    Acosta Haab, G.
    Falcoff, N.
    Guman, G.
    Dalurzo, L.
    Iotti, A.
    Martin, M. E.
    Olmedo, G.
    Raya, M.
    Reginatto, A.
    Werbach, A.
    Demellis, G.
    Labanca, M. J.
    Leguina, L.
    Mora, M. F.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1178 - S1178